SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Senores Pharmaceutic - Quaterly Results

15 May 2026 Evaluate
The total revenue surged to Rs. 368.10 millions, up 210.37% for the March 2026 quarter as against Rs. 118.60 millions during the year-ago period.The company almost doubled its revenue to Rs. 84.80 millions  from Rs. 20.20 millions in the quarter ended March 2026.The company reported a good operating profit of 187.10 millions compared to 65.20 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 368.10 118.60 210.37 1060.90 385.40 175.27 1060.90 385.40 175.27
Other Income 221.90 92.50 139.89 663.50 219.90 201.73 663.50 219.90 201.73
PBIDT 187.10 65.20 186.96 476.70 147.10 224.07 476.70 147.10 224.07
Interest 18.90 23.50 -19.57 69.80 65.20 7.06 69.80 65.20 7.06
PBDT 168.20 41.70 303.36 406.90 81.90 396.83 406.90 81.90 396.83
Depreciation 41.30 12.70 225.20 132.30 30.80 329.55 132.30 30.80 329.55
PBT 126.90 29.00 337.59 274.60 51.10 437.38 274.60 51.10 437.38
TAX 42.10 8.80 378.41 72.10 14.20 407.75 72.10 14.20 407.75
Deferred Tax -22.70 4.00 -667.50 -12.40 -0.30 4033.33 -12.40 -0.30 4033.33
PAT 84.80 20.20 319.80 202.50 36.90 448.78 202.50 36.90 448.78
Equity 460.50 460.50 0.00 460.50 460.50 0.00 460.50 460.50 0.00
PBIDTM(%) 50.83 54.97 -7.54 44.93 38.17 17.73 44.93 38.17 17.73

Senores Pharmaceutic Share Price

1289.15 -2.10 (-0.16%)
15-Jun-2026 11:42 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1803.00
Dr. Reddys Lab 1286.00
Cipla 1384.70
Zydus Lifesciences 1099.00
Lupin 2282.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: